Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS MTPC Royalties Reach 19.5 Billion Yen from Out-Licensed Gilenya
May 10, 2013
-
BUSINESS Takeda Sees Sales Rise on Expanding Europe, Emerging Market Biz in FY2012, Yet Operating Profit Sags 50%
May 10, 2013
-
BUSINESS No Prospects of Reaching Agreement on Delivery Prices with Wholesalers Even after the Fiscal Year End: Pres. Tajiri of Medical System Network
May 10, 2013
-
BUSINESS Takeda to Acquire US Dengue Vaccine Developer Inviragen
May 9, 2013
-
BUSINESS IFRS Implications to Be Seen in In-Licensed Products, M&A Processing
May 9, 2013
-
ORGANIZATION Kyokai Kenpo Launches Trial Notification Service on Copayment Differences between Original, Generic Anti-Allergy Drugs
May 8, 2013
-
ACADEMIA Nat’l University Hospitals Sharing Information of Drug Purchase Prices through Central Database
May 7, 2013
-
BUSINESS Boehringer to Enter Oncology Market, Hire 100 MRs in Japan
May 2, 2013
-
BUSINESS Novartis Investigating Employee Involvement in Retracted Diovan Papers
May 1, 2013
-
REGULATORY First Committee Recommends Approval for New Gout, Hyperuricemia Treatment, Antihypertensive Tape Formulation
May 1, 2013
-
REGULATORY PMRJ Introduces “RS Expert Certification System”
April 30, 2013
-
BUSINESS Boehringer Filed NDA for Afatinib in Japan: Chairman
April 26, 2013
-
BUSINESS Edoxaban Will Be Key to Achieving Targets in Daiichi Sankyo’s New 5-Year Business Plan
April 26, 2013
-
ORGANIZATION Itsuro Yoshida of Towa Pharmaceutical Expected to Take Over as Next President of JGA
April 25, 2013
-
REGULATORY Bill to Amend PAL Will Be Submitted to Diet in May, as Instructed by PM Abe: Mr Akagawa of PFSB
April 25, 2013
-
ACADEMIA RA Treatment Guidelines to Reflect Patients’ Values and Economic Considerations as Well as Evidence
April 24, 2013
-
ACADEMIA New COPD Guidelines Recommend LAMA, LABA on Equal Footing
April 23, 2013
-
BUSINESS Pfizer-Mylan Pair’s Japan Generic Share at 2.8%, Aspire for Bigger Slice of Market
April 22, 2013
-
BUSINESS Tug-of-War over “Conflicts of Interest” (2): “Diovan Scandal” Brings Renewed Attention to COI
April 19, 2013
-
BUSINESS Novo Nordisk Ups Efforts in Basal Insulin Market, Pits Tresiba against Lantus
April 18, 2013
ページ
Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…